Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00689
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting

Rambam Maimonides Medical Journal
Medicine
2014English

Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2007English

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

Journal of Clinical Medicine
2017English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Refractory Chronic Lymphocytic Leukemia – New Therapeutic Strategies

Oncotarget
Oncology
2010English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy